| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |